🇺🇸 FDA

Drug profile · INN

adenosine

ADENOSINE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

adenosine (ADENOSINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN adenosine
Brand ADENOSINE
Route INJECTION
Formulation INJECTABLE
Originator Regeneron Ireland Designated Activity Company (DAC)

Related patents

Search patents →

  1. US 12378248

    A1 adenosine receptor agonists and methods of use thereof

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12325708

    Adenosine 2 receptor antagonists

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12310965

    Treatment of cancer utilizing an identified adenosine fingerprint

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12213990

    A3 adenosine receptor ligand for use for achieving a fat loss effect

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12174192

    Methods for detecting and treating cancers having adenosine pathway activation

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12168023

    Inhibitors of adenosine 5′-nucleotidase

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12116635

    Methods for detecting and treating cancers having adenosine pathway activation

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11795443

    Uses of adenosine base editors

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is adenosine?

adenosine (ADENOSINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for adenosine?

ADENOSINE is a marketed brand name for adenosine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of adenosine?

adenosine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.